Regentis extends SAGE clinical trial of GelrinC for knee pain
Regentis Biomaterials has expanded the SAGE clinical trial of GelrinC for treating articular cartilage damage in the knee…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Oct 18
Regentis Biomaterials has expanded the SAGE clinical trial of GelrinC for treating articular cartilage damage in the knee…
23 Oct 18
Shoulder Innovations, a developer of shoulder replacement systems, has secured $2.5m in series A equity funding led by…
19 Oct 18
Synoste, a Finnish medical device company, has raised over €5m to start clinical investigations and to develop new…
19 Oct 18
Viseon has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Voyant system for…
16 Oct 18
Field Orthopaedics has formed exclusive partnership with Ortho Consulting Group for the launch of new micro screw in…
12 Oct 18
Medical device company Catalyst OrthoScience has introduced the patent pending 3-Peg Glenoid implant to its Catalyst CSR Total…
11 Oct 18
Wright Medical Group, a company focused on extremities and biologics products, has completed the acquisition of orthopedic medical…
08 Oct 18
UK-based Corin Group has signed a binding agreement to acquire Australian orthopaedic implant designer and manufacturer Global Orthopaedic…
04 Oct 18
The US Food and Drug Administration (FDA) has approved CarboFix in Orthopedics’ CarboClear carbon fiber transverse connectors for…
04 Oct 18
Medical grade silicon nitride manufacturer Amedica has completed the sale of its spine business to CTL Medical for…